The introduction of two rival bills has intensified the long-simmering debate on biosimilars regulation in the US.
Jul 1, 2009
By:
Brian J. Del Buono, PhD
The introduction of two rival bills has intensified the long-simmering debate on biosimilars regulation in the US.
|